TGFB1, which was upregulated in Ob-NAFLD group, promotes the release of inflammation mediators, remodeling and collagen deposition in WAT [39,40,41]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.